Literature DB >> 26453843

Keeping CRISPR/Cas on-Target.

Muhammad Jamal1, Faheem Ahmed Khan, Lin Da, Zeshan Habib, Jinxia Dai, Gang Cao.   

Abstract

CRISPR/Cas, a microbial adaptive immune system, has recently been reshaped as a versatile genome editing approach, endowing genome engineering with high efficiency and robustness. The DNA endonuclease Cas, a component of CRISPR system, is directed to specific target within genomes by guide RNA (gRNA) and performs gene editing function. However, the system is still in its infancy and facing enormous challenges such as off-target mutation. Lots of attempts have been made to overcome such off-targeting and proven to be effective. In this review we focused on recent progress of increasing the CRISPR specificity realized by rational design of gRNA and modification of Cas9 endonuclease. Meanwhile the methods to screen off-target mutation and their effects are also discussed. Comprehensive consideration and rational design to reduce off-target mutation and selection of effective screening assay will greatly facilitate to achieve successful CRISPR/Cas system mediated gene editing.

Entities:  

Mesh:

Year:  2015        PMID: 26453843

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  16 in total

Review 1.  Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques.

Authors:  Galaxy Y Cho; Kyle Bolo; Karen Sophia Park; Jesse D Sengillo; Stephen H Tsang
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 2.  Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.

Authors:  Shengdar Q Tsai; J Keith Joung
Journal:  Nat Rev Genet       Date:  2016-05       Impact factor: 53.242

3.  Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.

Authors:  Evan M Kerek; Christopher R Cromwell; Basil P Hubbard
Journal:  Methods Mol Biol       Date:  2021

Review 4.  CRISPR/Cas technology for improving nutritional values in the agricultural sector: an update.

Authors:  Mayank Chaudhary; Tapan Kumar Mukherjee; Raj Singh; Mahiti Gupta; Soniya Goyal; Paavan Singhal; Rakesh Kumar; Nabin Bhusal; Pooja Sharma
Journal:  Mol Biol Rep       Date:  2022-05-14       Impact factor: 2.742

Review 5.  CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING.

Authors:  Galaxy Y Cho; Kellie A Schaefer; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Retina       Date:  2018-08       Impact factor: 4.256

Review 6.  CRISPR/Cas9 for the Clinician: Current uses of gene editing and applications for new therapeutics in oncology.

Authors:  Julia Boland; Elena Nedelcu
Journal:  Perm J       Date:  2020-12

Review 7.  CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.

Authors:  Seyed Ahmad Rasoulinejad; Faezeh Maroufi
Journal:  Mol Biotechnol       Date:  2021-05-31       Impact factor: 2.695

Review 8.  Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts.

Authors:  Zeribe C Nwosu; Hamed Alborzinia; Stefan Wölfl; Steven Dooley; Yan Liu
Journal:  Front Physiol       Date:  2016-06-01       Impact factor: 4.566

Review 9.  CRISPR guide RNA design for research applications.

Authors:  Stephanie E Mohr; Yanhui Hu; Benjamin Ewen-Campen; Benjamin E Housden; Raghuvir Viswanatha; Norbert Perrimon
Journal:  FEBS J       Date:  2016-06-22       Impact factor: 5.542

Review 10.  CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.

Authors:  Faheem Ahmed Khan; Nuruliarizki Shinta Pandupuspitasari; Huang Chun-Jie; Zhou Ao; Muhammad Jamal; Ali Zohaib; Farhan Ahmed Khan; Muthia Raihana Hakim; Zhang ShuJun
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.